Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Appili Therapeutics Inc
APLICurrent price
0.04 CAD
+0.005 CAD (+14.29%)
Last closed
0.035 CAD
Company
www.appilitherapeutics.com
ISIN
CA03783R1073
Sector
Healthcare
Industry
Biotechnology
Exchange
Toronto Exchange
Capitalization
4 247 642 CAD
Yield for 12 month
+14.29 %
1Y
3Y
5Y
10Y
15Y
APLI
Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada. Its anti-infective portfolio includes ATI-1501, a taste-masked liquid oral suspension formulation of the antibiotic metronidazole to treat anaerobic bacterial, protozoal, and parasitic infections; ATI-1801, a novel topical formulation of paromomycin in Phase III clinical trials for the treatment of cutaneous leishmaniasis and disfiguring skin infections; and ATI-1701, which is a live-attenuated vaccine in preclinical trials for Francisella tularensis. The company was incorporated in 2015 and is headquartered in Halifax, Canada. Address: #21-1344 Summer Street, Halifax, NS, Canada, B3H 0A8
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
0.21 CADP/E ratio
–Dividend Yield
–Current Year
+828 056 CAD
Last Year
+334 439 CAD
Current Quarter
–
Last Quarter
+11 706 CAD
Current Year
+814 383 CAD
Last Year
+328 169 CAD
Current Quarter
-3 367 CAD
Last Quarter
+8 485 CAD
Key Figures APLI
1 year
3 years
5 years
10 years
EBITDA
-8 597 163 CAD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-244.22 %
PEG Ratio
–
Return On Equity TTM
-938.72 %
Wall Street Target Price
0.21 CAD
Revenue TTM
828 056 CAD
Book Value
-0.1 CAD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-96.5 %
Dividend Yield
–
Gross Profit TTM
1 391 776 CAD
Earnings per share
-0.03 CAD
Diluted Eps TTM
-0.03 CAD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics APLI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History APLI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation APLI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
2.3776
Enterprise Value Revenue
16.9144
Price Sales TTM
5.1297
Enterprise Value EBITDA
-3.6137
Price Book MRQ
1.3981
Financials APLI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators APLI
For 52 weeks
0.025 CAD
0.06 CAD
50 Day MA
0.033 CAD
Shares Short Prior Month
3 563
200 Day MA
0.035 CAD
Short Ratio
0.03
Shares Short
11 123
Short Percent
0.56 %
BeatStart